表紙:マイクロアレイの世界市場予測(2021年~2027年)
市場調査レポート
商品コード
1025429

マイクロアレイの世界市場予測(2021年~2027年)

Microarray Market 2021-2027

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.50円
マイクロアレイの世界市場予測(2021年~2027年)
出版日: 2021年07月15日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のマイクロアレイの市場規模は、予測期間中に7.8%の大幅なCAGRで拡大すると予想されています。世界のマイクロアレイ市場を牽引しているのは、癌の有病率の上昇と、ゲノム研究への資金提供の増加です。さらに、急速に進化する情報技術やソフトウェア技術、新興のバイオインフォマティクスもマイクロアレイ市場を牽引する要因であり、費用対効果が高く、信頼性が高く、長期的に利用できるものとなっています。しかし、熟練した専門家の不足や、次世代DNAシーケンス技術の浸透が市場成長の大きな課題であると考えられます。

世界のマイクロアレイ市場は、COVID-19パンデミックの際に、ワクチンの製造、新薬の開発、テストキットの展開などに多大な努力が払われ、バイオテクノロジー分野の成長に拍車がかかったことで、プラス成長を遂げました。また、COVID-19のパンデミックにより、医薬品研究におけるマイクロアレイ技術の使用が増加しました。

当レポートでは、世界のマイクロアレイ市場について調査分析し、市場概要、市場決定要因、市場区分、競合情勢、地域別分析、主要企業などについて、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と最新市場動向
  • 規制

第3章 競合情勢

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
  • 主要戦略分析
  • 主要企業に対するCOVID-19の影響

第4章 市場の決定要因

  • 成長要因
  • 抑制要因
  • 市場機会

第5章 市場セグメンテーション

  • タイプ別の世界のマイクロアレイ市場
    • DNAマイクロアレイ
    • タンパク質マイクロアレイ
    • ペプチドマイクロアレイ
    • 組織マイクロアレイ
    • その他(セルラーマイクロアレイ)
  • アプリケーション別の世界のマイクロアレイ市場
    • 診断と予後
    • 薬理ゲノミクスとセラグノスティック
    • 創薬
    • その他

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • その他の地域

第7章 企業プロファイル

  • Abcam PLC
  • Agilent Technologies, Inc.
  • Applied Microarrays, Inc.
  • Arrayit Corp.
  • Aurora Biomed Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Meso Scale Diagnostics, LLC.
  • Origene Technologies, Inc.
  • Pantomics, Inc.
  • Partek, Inc.
  • PerkinElmer, Inc.
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • US Biomax, Inc.
  • Illumina, Inc.
  • Indevr, Inc.
  • Luminex Corp.
  • RayBiotech, Inc.
図表

LIST OF TABLES

  • 1. GLOBAL MICROARRAY MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION) 2020-2027 ($ MILLION)
  • 2. GLOBALDNA MICROARRAYSMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 3. GLOBAL PROTEIN MICROARRAY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 4. GLOBAL PEPTIDE MICROARRAYMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL TISSUE MICROARRAYMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL OTHERMICROARRAYMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBALMICROARRAY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 8. GLOBALMICROARRAY FOR DIAGNOSIS AND PROGNOSISMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 9. GLOBAL MICROARRAY FOR PHARMACOGENOMICS AND THERAGNOSTICMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL MICROARRAY FOR DRUG DISCOVERYMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL MICROARRAY FOR OTHER APPLICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL MICROARRAY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 13. NORTH AMERICAN MICROARRAY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 14. NORTH AMERICAN MICROARRAY MARKET RESEARCH AND ANALYSIS BYTYPE,2020-2027 ($ MILLION)
  • 15. NORTH AMERICAN MICROARRAY MARKET RESEARCH AND ANALYSIS BY APPLICATION,2020-2027 ($ MILLION)
  • 16. EUROPEAN MICROARRAY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 17. EUROPEAN MICROARRAY MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 18. EUROPEAN MICROARRAY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 19. ASIA-PACIFIC MICROARRAY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 20. ASIA-PACIFIC MICROARRAY MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 21. ASIA-PACIFIC MICROARRAY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 22. REST OF THE WORLD MICROARRAY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 23. REST OF THE WORLD MICROARRAY MARKET RESEARCH AND ANALYSIS BY TYPE2020-2027 ($ MILLION)
  • 24. REST OF THE WORLD MICROARRAY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL MICROARRAY MARKET, 2020-2027 (% MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL MICROARRAY MARKET BY SEGMENT, 2020-2027 (% MILLION)
  • 3. RECOVERY OF GLOBAL MICROARRAY MARKET, 2020-2027 (%)
  • 4. GLOBAL MICROARRAY MARKET SHARE BY TYPE,2020 VS 2027 (%)
  • 5. GLOBAL MICROARRAY MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 6. GLOBAL MICROARRAY MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 7. GLOBAL DNA MICROARRAY MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 8. GLOBALPROTEIN MICROARRAY MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. GLOBAL PEPTIDE MICROARRAY MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 10. GLOBAL TISSUE MICROARRAY MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 11. GLOBAL OTHERS (CELLULAR MICROARRAY)MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 12. GLOBAL DIAGNOSIS AND PROGNOSISMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 13. GLOBALPHARMACOGENOMICS AND THERAGNOSTICMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 14. GLOBAL DRUG DISCOVERYMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 15. GLOBAL OTHERS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 16. US MICROARRAY MARKETSIZE, 2020-2027($ MILLION)
  • 17. CANADA MICROARRAY MARKETSIZE, 2020-2027($ MILLION)
  • 18. UK MICROARRAY ANDPROTEIN MICROARRAYMARKET SIZE, 2020-2027($ MILLION)
  • 19. FRANCE MICROARRAY MARKETSIZE, 2020-2027($ MILLION)
  • 20. GERMANY MICROARRAY MARKETSIZE, 2020-2027($ MILLION)
  • 21. ITALY MICROARRAY MARKETSIZE, 2020-2027($ MILLION)
  • 22. SPAIN MICROARRAY MARKETSIZE, 2020-2027($ MILLION)
  • 23. REST OF EUROPE MICROARRAY MARKETSIZE, 2020-2027($ MILLION)
  • 24. INDIA MICROARRAY MARKETSIZE, 2020-2027($ MILLION)
  • 25. CHINA MICROARRAY MARKETSIZE, 2020-2027($ MILLION)
  • 26. JAPAN MICROARRAY MARKETSIZE, 2020-2027($ MILLION)
  • 27. SOUTH KOREA MICROARRAY MARKETSIZE, 2020-2027($ MILLION)
  • 28. REST OF ASIA-PACIFIC MICROARRAY MARKETSIZE, 2020-2027($ MILLION)
  • 29. REST OF THE WORLD MICROARRAY MARKETSIZE, 2020-2027($ MILLION)
目次
Product Code: OMR2023861

Full-title:Global Microarray Market Size, Share & Trends Analysis Report by Type (DNA Microarrays, Protein Microarray, Peptide Microarray, Tissue Microarray, and Others) By Application (Diagnosis & Prognosis, Pharmacogenomics & Theragnostic, Drug Discovery, and Others) Forecast Period, 2021-2027.

The global microarray market is anticipated to grow at a substantial CAGR of 7.8% during the forecast period. The global microarray market is driven by the rising prevalence of cancer as well as increased funding for genomic research. Additionally, the rapidly evolving information and software technology, as well as emerging bioinformatics, are also some of the factors driving the microarray market, making it cost-effective, dependable, and long-lasting. However, a lack of skilled professionals and the growing penetration of next-generation DNA sequencing techniques are considered to address significant challenges to market growth.

The global microarray market witnessed positive growth during the COVID-19 pandemic as huge efforts to manufacture vaccines, develop new drugs, deployment of test kits was fueling the growth of the biotechnology sector. The COVID-19 pandemic has also increased the use of microarrays techniques in pharmaceutical research.

The global microarray market is segmented based on type, and application; Based on type, the market is segmented into DNA microarrays, protein microarray, peptide microarray, tissue microarray, and others (cellular microarray). Further based on application, the market is segregated into diagnosis and prognosis, Pharmacogenomics and theragnostic, and drug discovery, and others. The DNA Microarray segment is expected to have a significant share of the global microarray market attributing to the increasing applications of the DNA microarray approach in various sectors, such as gene expression, proteomics, disease monitoring, and drug discovery.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific is the fastest-growing market for microarray. Factors such as increased emphasis on personalized medicine, an increase in cancer diagnostic rates, and technological advancements are largely responsible for fueling the growth of this market. The Asia-Pacific region is also expected to grow significantly as a result of increased government funding in the healthcare sector. As per IBEF, the healthcare sector in India received $679 million in investment in 2018. These government initiatives are expected to increase demand for microarrays used in research, therefore, fueling the demand for microarrays in the Asia-Pacific market.

Research Methodology

The market study of the global microarray market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Whitepapers, research papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Microarray Market Research and Analysis by Type
  • Global Microarray Market Research and Analysis by Application

The Report Covers:

  • Comprehensive research methodology of the global microarray market
  • This report also includes a detailed and extensive market overview with key analyst insights
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations
  • Analysis of regional regulations and other government policies impacting the global microarray market
  • Insights about market determinants that are stimulating the global microarray market
  • Detailed and extensive market segments with the regional distribution of forecasted revenues
  • Extensive profiles and recent developments of market players

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
    • Current Industry Analysis and Growth Potential Outlook
    • Impact of COVID-19 on the Global Microarray Industry
    • Recovery Scenario of Global Microarray Industry
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Regulations

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on key players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Microarray Marketby Type
    • 5.1.1. DNA Microarrays
    • 5.1.2. Protein Microarray
    • 5.1.3. Peptide Microarray
    • 5.1.4. Tissue Microarray
    • 5.1.5. Others (Cellular Microarray)
  • 5.2. Global Microarray Marketby Application
    • 5.2.1. Diagnosis and Prognosis
    • 5.2.2. Pharmacogenomics and Theragnostic
    • 5.2.3. Drug Discovery
    • 5.2.4. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abcam PLC
  • 7.2. Agilent Technologies, Inc.
  • 7.3. Applied Microarrays, Inc.
  • 7.4. Arrayit Corp.
  • 7.5. Aurora Biomed Inc.
  • 7.6. Bio-Rad Laboratories, Inc.
  • 7.7. F. Hoffmann-La Roche Ltd.
  • 7.8. Merck KGaA
  • 7.9. Meso Scale Diagnostics, LLC.
  • 7.10. Origene Technologies, Inc.
  • 7.11. Pantomics, Inc.
  • 7.12. Partek, Inc.
  • 7.13. PerkinElmer, Inc.
  • 7.14. Takara Bio, Inc.
  • 7.15. Thermo Fisher Scientific, Inc.
  • 7.16. US Biomax, Inc.
  • 7.17. Illumina, Inc.
  • 7.18. Indevr, Inc.
  • 7.19. Luminex Corp.
  • 7.20. RayBiotech, Inc.